ACT Enact Holdings, Inc. - Common Stock
$43,00
Prezzo · Mag 20, 2026
Fondamentali al Mag 6, 2026
Intervallo 52 sett.
$34–$45
83% of range
Rating Analisti
HOLD
9 analysts
Prezzo Obiettivo
$46
+6% upside
P/E (TTM)
8.8
ROE
12.8%
Margine di Profitto Netto
54.6%
ACT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$43.00
Capitalizzazione di Mercato
$5.64B
P/E (TTM)
8.8
EPS (TTM)
$4.52
Ricavi (TTM)
$1.24B
Rendimento div.
2.1%
ROE
12.8%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$34 – $45
ACT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$1.24B
2019-12-31
→
2025-12-31
EPS
$4.52
2019-12-31
→
2025-12-31
Flusso di cassa libero
—
Margini
54.6%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ACT
Mediana dei peer
P/E (TTM)
8.8
8.4
P/S (TTM)
4.6
4.2
P/B
1.1
1.3
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ACT
Mediana dei peer
Net Profit Margin (Margine di Profitto Netto)
54.6%
31.8%
ROA
10.1%
1.9%
ROE
12.8%
12.8%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ACT
Mediana dei peer
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ACT
Mediana dei peer
Revenue YoY (Ricavi YoY)
2.8%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
4.1%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
2.2%
—
EPS YoY
3.4%
—
Net Income YoY (Utile Netto YoY)
-2.0%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ACT
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
17.9%
—
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
2.1%
Rapporto di Distribuzione Utili
17.9%
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 26 Febbraio 2026 | $0,2100 |
| 21 Novembre 2025 | $0,2100 |
| 18 Agosto 2025 | $0,2100 |
| 19 Maggio 2025 | $0,2100 |
| 21 Febbraio 2025 | $0,1850 |
| 18 Novembre 2024 | $0,1850 |
| 28 Agosto 2024 | $0,1850 |
| 29 Maggio 2024 | $0,1850 |
| 27 Febbraio 2024 | $0,1600 |
| 15 Novembre 2023 | $0,8700 |
| 30 Agosto 2023 | $0,1600 |
| 30 Maggio 2023 | $0,1600 |
| 22 Febbraio 2023 | $0,1400 |
| 17 Novembre 2022 | $1,2600 |
| 25 Agosto 2022 | $0,1400 |
| 06 Maggio 2022 | $0,1400 |
| 24 Novembre 2021 | $1,2300 |
ACT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
9 analisti
- Acquisto forte 2 22,2%
- Compra 2 22,2%
- Mantieni 5 55,6%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
4 analisti · 2026-05-15
Mediana
$45.50
← Sotto tutti i target
$43.00
Basso
$44.00
Alto
$48.00
Target mediano
$45.50
+5,8%
Target medio
$45.75
+6,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.04%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $1.21 | $1.18 | 0.03% |
| 31 Dicembre 2025 | $1.23 | $1.10 | 0.13% |
| 30 Settembre 2025 | $1.12 | $1.10 | 0.02% |
| 30 Giugno 2025 | $1.15 | $1.11 | 0.04% |
| 31 Marzo 2025 | $1.10 | $1.09 | 0.01% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ACT | $5.64B | 8.8 | 2.8% | 54.6% | 12.8% | — |
| RKT | — | -387.2 | 27.6% | -54.4% | -0.45% | — |
| MTG | $6.41B | 9.3 | 0.49% | 60.8% | 14.3% | — |
| RDN | $4.88B | 8.7 | -0.76% | 48.7% | 12.4% | — |
| UWMC | — | 36.5 | 18.2% | 0.87% | 1.6% | — |
| PFSI | $6.86B | 14.2 | -25.2% | 2491.9% | 12.0% | — |
| NMIH | $3.11B | 8.3 | 8.5% | 55.0% | 15.5% | — |
| MBIN | — | — | — | — | — | — |
| AGM | — | 10.6 | 8.9% | 50.8% | 12.7% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.24B | $1.20B | $1.15B | $1.10B | $1.12B | $1.11B | |
| SG&A Expense | $208M | $213M | $212M | $227M | $231M | $215M | |
| Interest Expense | $50M | $51M | $52M | $52M | $51M | $18M | |
| Pretax Income | $859M | $878M | $852M | $898M | $695M | $472M | |
| Income Tax | $185M | $190M | $186M | $194M | $149M | $102M | |
| Net Income | $674M | $688M | $666M | · | $547M | $370M | |
| EPS (Basic) | $4.54 | $4.40 | $4.14 | $4.32 | $3.36 | $2.27 | |
| EPS (Diluted) | $4.52 | $4.37 | $4.11 | $4.31 | $3.36 | $2.27 | |
| Shares (Basic) | 148,373,000 | 156,277,000 | 160,870,000 | 162,838,000 | 162,840,000 | 162,840,000 | |
| Shares (Diluted) | 149,318,000 | 157,554,000 | 161,847,000 | 163,294,000 | 162,879,000 | 162,840,000 |
Stato Patrimoniale 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $582M | $599M | $616M | $514M | $426M | $453M | |
| Short-term Investments | $0 | $3M | $20M | $3M | $0 | $0 | |
| Total Assets | $6.89B | $6.52B | $6.19B | $5.71B | $5.87B | $5.65B | |
| Deferred Tax | · | · | · | $0 | $2M | $37M | |
| Total Liabilities | $1.54B | $1.53B | $1.56B | $1.61B | $1.76B | $1.77B | |
| Long-term Debt | $744M | $743M | $745M | $743M | $740M | $738M | |
| Common Stock | $1M | $2M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $1.71B | $2.08B | $2.31B | $2.38B | $2.37B | $2.37B | |
| Retained Earnings | $3.68B | $3.13B | $2.55B | $2.10B | $1.65B | $1.30B | |
| AOCI | $-30M | $-207M | $-230M | $-383M | $84M | $208M | |
| Stockholders' Equity | $5.36B | $5.00B | $4.63B | $4.10B | $4.11B | $3.88B | |
| Liabilities + Equity | $6.89B | $6.52B | $6.19B | $5.71B | $5.87B | $5.65B | |
| Shares Outstanding | 142,209,000 | 152,318,000 | 159,344,000 | 162,779,000 | 162,840,000 | 162,840,000 |
Flusso di cassa 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $19M | $15M | $10M | $1M | $0 | |
| Deferred Tax | $8M | $4M | $-2M | $-2M | $-1M | $11M | |
| Operating Cash Flow | $725M | $686M | $632M | $561M | $572M | $704M | |
| Investing Cash Flow | $-226M | $-321M | $-229M | $-220M | $-399M | $-1.14B | |
| Debt Issued | $0 | $750M | $0 | $0 | $0 | $738M | |
| Net Debt Issued | $0 | $750M | · | $0 | $0 | · | |
| Stock Repurchased | $382M | $244M | $88M | $2M | $0 | $0 | |
| Net Stock Activity | $-382M | $-244M | $-88M | $-2M | · | · | |
| Dividends Paid | $121M | $112M | $213M | $251M | $200M | $437M | |
| Financing Cash Flow | $-515M | $-382M | $-301M | $-252M | $-200M | $300M | |
| Net Change in Cash | $-17M | $-16M | $102M | $88M | $-27M | $-132M | |
| Taxes Paid | $191M | $189M | $182M | · | · | · |
Redditività 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Margin | 54.6% | · | · | · | 48.9% | · | |
| Pretax Margin | 69.5% | 73.1% | 73.8% | 82.0% | 62.2% | · | |
| ROA | 10.1% | · | · | · | 9.5% | · | |
| ROE | 12.8% | · | · | · | 13.2% | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | · |
Tassi di Crescita 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.8% | 4.2% | 5.4% | -2.0% | 1.0% | · | |
| Revenue CAGR 3Y | 4.1% | 2.4% | 1.4% | · | · | · | |
| Revenue CAGR 5Y | 2.2% | · | · | · | · | · | |
| EPS YoY | 3.4% | 6.3% | -4.6% | 28.3% | 48.0% | · | |
| EPS CAGR 3Y | 1.6% | 9.2% | 21.9% | · | · | · | |
| EPS CAGR 5Y | 14.8% | · | · | · | · | · | |
| Net Income YoY | -2.0% | 3.4% | · | · | 47.6% | · | |
| Net Income CAGR 3Y | · | 8.0% | 21.6% | · | · | · | |
| Net Income CAGR 5Y | 12.7% | · | · | · | · | · | |
| Dividend CAGR 5Y | -22.7% | · | · | · | · | · |
Valutazione (TTM) 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.24B | $1.20B | $1.15B | $1.10B | $1.12B | · | |
| Net Income TTM | $674M | $688M | $666M | $637M | $547M | · | |
| Market Cap | $5.64B | $4.93B | $4.60B | $3.93B | $3.37B | · | |
| P/E | 8.8 | 7.4 | 7.0 | 5.6 | 6.2 | · | |
| P/S | 4.6 | 4.1 | 4.0 | 3.6 | 3.0 | · | |
| P/B | 1.1 | 1.0 | 1.0 | 1.0 | 0.8 | · | |
| P / Tangible Book | 1.1 | 1.0 | 1.0 | 1.0 | 0.8 | · | |
| P / Cash Flow | 7.8 | 7.2 | 7.3 | 7.0 | 5.9 | · | |
| Dividend Yield | 2.1% | 2.3% | 4.6% | 6.4% | 5.9% | · | |
| Earnings Yield | 11.4% | 13.5% | 14.2% | 17.9% | 16.3% | · | |
| Payout Ratio | 17.9% | · | · | · | 36.6% | · | |
| Annual Payout | $121M | $112M | $213M | $251M | $200M | · |
Conto Economico 9
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $312M | $313M | $311M | $305M | $307M | $302M | $310M | $299M | $292M | $296M | $299M | $278M | $281M | $277M | $275M | $274M | |
| Interest Expense | $12M | $12M | $13M | $12M | $12M | $12M | $12M | $14M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | |
| Pretax Income | $213M | $223M | $210M | $215M | $211M | $208M | $229M | $235M | $206M | $200M | $213M | $214M | $225M | $183M | $245M | $261M | |
| Income Tax | $46M | $46M | $46M | $47M | $46M | $45M | $49M | $51M | $45M | $42M | $49M | $46M | $49M | $39M | $54M | $56M | |
| Net Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $205M | |
| EPS (Basic) | $1.18 | $1.22 | $1.11 | $1.12 | $1.09 | $1.06 | $1.16 | $1.17 | $1.01 | $0.99 | $1.03 | $1.04 | $1.08 | $0.88 | $1.17 | $1.26 | |
| EPS (Diluted) | $1.18 | $1.23 | $1.10 | $1.11 | $1.08 | $1.05 | $1.15 | $1.16 | $1.01 | $0.97 | $1.02 | $1.04 | $1.08 | $0.88 | $1.17 | $1.25 | |
| Shares (Basic) | 141,595,000 | -300,832,000 | 147,434,000 | 149,940,000 | 151,831,000 | -315,295,000 | 155,561,000 | 157,193,000 | 158,818,000 | -322,956,000 | 160,066,000 | 161,318,000 | 162,442,000 | -325,688,000 | 162,843,000 | 162,842,000 | |
| Shares (Diluted) | 142,634,000 | -302,658,000 | 148,340,000 | 150,729,000 | 152,907,000 | -318,120,000 | 157,016,000 | 158,571,000 | 160,087,000 | -324,649,000 | 161,146,000 | 162,171,000 | 163,179,000 | -326,361,000 | 163,376,000 | 163,225,000 |
Stato Patrimoniale 13
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $549M | $582M | $544M | $613M | $635M | $599M | $673M | $699M | $614M | · | $678M | $691M | $622M | · | $536M | $584M | |
| Short-term Investments | · | $0 | $2M | $3M | $4M | $3M | $2M | $12M | $10M | · | $18M | $11M | $2M | · | $2M | · | |
| Total Assets | $6.96B | $6.89B | $6.88B | $6.77B | $6.72B | $6.52B | $6.60B | $6.35B | $6.30B | · | $6.00B | $5.92B | $5.84B | · | $5.72B | $5.76B | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Total Liabilities | $1.62B | $1.54B | $1.56B | $1.55B | $1.60B | $1.53B | $1.56B | $1.52B | $1.59B | · | $1.54B | $1.55B | $1.55B | · | $1.61B | $1.68B | |
| Long-term Debt | $745M | $744M | $744M | $744M | $743M | $743M | $743M | $742M | $746M | · | $745M | $744M | $743M | · | $742M | $742M | |
| Common Stock | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | |
| Paid-in Capital | $1.61B | $1.71B | $1.83B | $1.93B | $2.01B | $2.08B | $2.15B | $2.22B | $2.26B | · | $2.32B | $2.32B | $2.36B | · | $2.38B | $2.38B | |
| Retained Earnings | $3.82B | $3.68B | $3.53B | $3.40B | $3.26B | $3.13B | $2.99B | $2.84B | $2.69B | · | $2.53B | $2.40B | $2.25B | · | $2.16B | $1.99B | |
| AOCI | $-83M | $-30M | $-42M | $-104M | $-152M | $-207M | $-102M | $-236M | $-237M | · | $-400M | $-345M | $-320M | · | $-427M | $-293M | |
| Stockholders' Equity | $5.34B | $5.36B | $5.32B | $5.22B | $5.12B | $5.00B | $5.04B | $4.83B | $4.71B | $4.63B | $4.46B | $4.38B | $4.30B | $4.10B | $4.12B | $4.08B | |
| Liabilities + Equity | $6.96B | $6.89B | $6.88B | $6.77B | $6.72B | $6.52B | $6.60B | $6.35B | $6.30B | · | $6.00B | $5.92B | $5.84B | · | $5.72B | $5.76B | |
| Shares Outstanding | 140,293,000 | 142,209,000 | 145,566,000 | 148,385,000 | 150,765,000 | 152,318,000 | 154,450,000 | 156,111,000 | 157,704,000 | · | 159,995,000 | 160,234,000 | 161,938,000 | · | 162,843,000 | 162,842,000 |
Flusso di cassa 10
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $4M | $4M | $5M | $6M | $3M | $4M | $6M | $4M | $3M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $3M | $-80.0K | $5M | $-1M | $4M | $1M | $2M | $-77.0K | $1M | $-2M | $2M | $-4M | $3M | $-4M | $-62.0K | $-1M | |
| Operating Cash Flow | $224M | $186M | $192M | $120M | $227M | $166M | $188M | $145M | $187M | $190M | $155M | $168M | $119M | $158M | $100M | $141M | |
| Investing Cash Flow | $-125M | $10M | $-121M | $-26M | $-90M | $-137M | $-102M | $32M | $-113M | $-95M | $-136M | $-31M | $33M | $26M | $-126M | $26M | |
| Debt Issued | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | |
| Stock Repurchased | $93M | $127M | $106M | $85M | $65M | $75M | $71M | $49M | $50M | $18M | $6M | $41M | $22M | $2M | $0 | $0 | |
| Net Stock Activity | $-93M | · | · | · | $-65M | · | · | · | $-50M | · | · | · | $-22M | · | · | · | |
| Dividends Paid | $30M | $30M | $31M | $31M | $28M | $28M | $29M | $29M | $25M | $139M | $26M | $26M | $23M | $205M | $23M | $23M | |
| Financing Cash Flow | $-132M | $-157M | $-140M | $-116M | $-101M | $-103M | $-111M | $-92M | $-75M | $-157M | $-32M | $-67M | $-45M | $-207M | $-23M | $-23M | |
| Net Change in Cash | $-33M | $39M | $-69M | $-22M | $36M | $-74M | $-26M | $85M | $-1M | $-62M | $-13M | $70M | $108M | $-22M | $-48M | $144M |
Redditività 4
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 74.9% | |
| Pretax Margin | 68.4% | · | 67.4% | 70.3% | 68.9% | · | 74.1% | 78.6% | 70.6% | · | 71.3% | 77.2% | 79.9% | · | 88.9% | 95.4% | |
| ROA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 7.1% | |
| ROE | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 10.0% |
Efficienza 1
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.1 |
Valutazione (TTM) 9
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.24B | · | $1.23B | $1.22B | $1.21B | · | $1.20B | $1.17B | $1.15B | · | $1.13B | $1.11B | $1.10B | · | $1.10B | $1.10B | |
| Net Income TTM | $637M | · | $637M | $637M | $637M | · | $637M | $637M | $637M | · | $637M | $637M | $637M | · | $637M | $637M | |
| Market Cap | $5.73B | · | $5.58B | $5.51B | $5.24B | · | $5.61B | $4.79B | $4.92B | · | $4.36B | $4.03B | $3.70B | · | $3.61B | $3.50B | |
| P/E | 9.1 | · | 8.6 | 8.3 | 7.9 | · | 8.4 | 7.2 | 7.5 | · | 6.3 | 5.5 | 5.1 | · | 5.2 | 5.5 | |
| P/S | 4.6 | · | 4.5 | 4.5 | 4.3 | · | 4.7 | 4.1 | 4.3 | · | 3.8 | 3.6 | 3.4 | · | 3.3 | 3.2 | |
| P/B | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 0.9 | 0.9 | |
| P / Tangible Book | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 0.9 | 0.9 | |
| P / Cash Flow | 25.6 | · | · | · | 23.1 | · | · | · | 26.3 | · | · | · | 31.0 | · | · | · | |
| Earnings Yield | 10.9% | · | 11.6% | 12.1% | 12.7% | · | 11.9% | 13.8% | 13.3% | · | 15.8% | 18.1% | 19.7% | · | 19.3% | 18.2% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $1.24B | $1.20B | $1.15B | $1.10B | $1.12B |
| Utile netto | $674M | $688M | $666M | — | $547M |
| EPS Diluito | $4.52 | $4.37 | $4.11 | $4.31 | $3.36 |
Ultime notizie Notizie recenti che menzionano questa società
- Il titolo di Structure Therapeutics è in rialzo del 47%, ma un fondo è appena uscito completamente da una posizione da 2,6 milioni di dollari
- Perché l'acquisto di Alumis da 4 milioni di dollari da parte di un fondo sembra una scommessa su un farmaco rivoluzionario per l'autoimmunità
- ACT Energy Technologies Ltd. Annuncia un calo del reddito del primo trimestre
- Il mercato australiano notevolmente più alto
- ACT Energy Technologies Ltd. Segnala un calo dell'utile netto del quarto trimestre
- Il CEO di Prenetics Global esalta la crescita esplosiva di IM8 e prevede ricavi per 180-200 milioni di dollari alla conferenza
- Cosa sapere su questo sviluppatore di farmaci per l'obesità che ha appena attirato un nuovo investimento di 7 milioni di dollari
- Questa Biotech con un farmaco MS in Breakout Attira Investimenti da 8 Milioni di Dollari tra un Calo Azionario del 30%
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.